Cargando…
Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1
BACKGROUND: Pelizaeus-Merzbacher disease (PMD) is caused by point mutations or copy number changes in the proteolipid protein 1 gene (PLP1). PLP1 is exclusively localized in the myelin sheath of oligodendrocytes. Amino acid-substituted PLP1 protein is unable to fold properly and is subsequently degr...
Autores principales: | Kouga, Takeshi, Koizume, Shiro, Aoki, Shiho, Jimbo, Eriko, Yamagata, Takanori, Inoue, Ken, Osaka, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510973/ https://www.ncbi.nlm.nih.gov/pubmed/31110947 http://dx.doi.org/10.1016/j.ymgmr.2019.100474 |
Ejemplares similares
-
Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes
por: Numasawa-Kuroiwa, Yuko, et al.
Publicado: (2014) -
Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes
por: Numasawa-Kuroiwa, Yuko, et al.
Publicado: (2015) -
Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease
por: Epplen, Dirk B, et al.
Publicado: (2015) -
Pelizaeus-Merzbacher disease can be a differential diagnosis in males presenting with severe neonatal respiratory distress and hypotonia
por: Ueda, Ayako, et al.
Publicado: (2018) -
Pelizaeus-Merzbacher disease in siblings
por: Mittal, Amit, et al.
Publicado: (2010)